What is the ticker symbol for ARCA biopharma?

ARCA biopharma trades under the ticker ABIO on NASDAQ.

What sector does ARCA biopharma operate in?

ARCA biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABIO in a portfolio?

PortView shows ABIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ARCA biopharma (ABIO) Stock Analysis

NASDAQHealthcareBiotechnology

$28.80+1052.00%

1-year price historyRange $18.96 – $49.92

52-week range$28.80

$2.25$53.88

What ARCA biopharma does

ARCA biopharma, Inc. operates as a clinical-stage biopharmaceutical company dedicated to the creation and commercialization of genetically targeted therapies designed to address various cardiovascular ailments. The company's leading therapeutic programs feature two key candidates: Recombinant Nematode Anticoagulant Protein c2 (rNAPc2), known as AB201, which is currently being evaluated in a Phase IIb clinical trial for its potential in treating COVID-19. Gencaro (bucindolol hydrochloride), a distinctive pharmacogenetically-targeted beta-adrenergic receptor antagonist. This compound has already concluded its Phase IIb trial, demonstrating efficacy for the management of atrial fibrillation in patients afflicted with chronic heart failure. To further its research and development efforts, ARCA biopharma has established strategic collaborations. These include a partnership with LabCorp aimed at developing a genetic test for the GENETIC-AF clinical trial, as well as a research alliance with the Colorado Prevention Center (an academic research organization of the University of Colorado) focused on advancing and commercializing Gencaro. Founded in 2004, the company is based in Westminster, Colorado.

Key metrics

Market cap

$34.82M

P/E (TTM)

-4.90

EPS (TTM)

$-5.88

Beta

0.90

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$39.21

200-day avg

$30.93

52-week high

$53.88

52-week low

$2.25

CEO

Thomas A. Keuer

ETFs linked to ABIO

Broad-market and Healthcare sector ETFs an investor holding ARCA biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ABIO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ABIO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ARCA biopharma?: ARCA biopharma trades under the ticker ABIO on NASDAQ.
Which exchange is ABIO listed on?: ABIO is listed on NASDAQ.
What sector does ARCA biopharma operate in?: ARCA biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ABIO in a portfolio?: PortView shows ABIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.